Listing 1 - 4 of 4 |
Sort by
|
Choose an application
Chronic lymphocytic leukemia is a chronic blood disease affecting mature B lymphocytes. In chronic lymphocytic leukemia, there is a rise in the number of lymphocytes that can be explained, among others, by the inhibiton of the apoptosis of these cells. Apoptosis is a process of self-destruction of cells that is regulated by a system of anti-apoptotic and pro-apoptotic proteins. Overexpression of anti- apoptotic proteins, including Bcl-2, has been observed in chronic lymphocytic leukemia and this significant upregulation is thought to be one of the causes of this disease. Different strategies are possible to inhibit the rise in the abundance of Bcl-2 proteins such as the use of BH3 mimetic molecules that block the anti-apoptotic action or molecules that inhibit the synthesis of Bcl-2 proteins. Oblimersen, navitoclax ABT-199 and AT-101 are drug compounds recently developed that exploit these different therapeutic strategies. This master's thesis offers an update on the current clinical studies, as well as on the efficacy and the side effects of these four molecules.
Choose an application
Breast Neoplasms --- Immunohistochemistry --- Proto-Oncogene Proteins c-bcl-2 --- Tissue Fixation --- Glutathione --- metabolism --- methods
Choose an application
Apoptosis --- Capsid --- Proto-Oncogene Proteins c-bcl-2 --- Cell Transformation, Neoplastic --- genetics --- physiology --- metabolism
Choose an application
In this book, scientists pioneering the field have compiled a series of focused chapters to highlight the relevance of the BCL‑2 family of proteins in apoptosis, physiology and disease. An important focus of this volume is considering the potential TH ERA PEUT IC benefits of targeting apoptosis pathways in the context of human disease. Readers interested in understanding how a cell handles stress and the consequences of dysregulation of this process for human disease will find this book very valuable. It attempts to describe a fascinating area of research where physiology and biomedicine converge at different levels, revealing a trip from the molecular regulation of apoptosis to the impact of this process to the physiology of a whole organism.
Apoptosis. --- Tumor proteins. --- Apoptosis --- Tumor proteins --- Bcl-2 protein family. --- Apoptosis Regulatory Proteins --- Cell Death --- Biological Science Disciplines --- Medicine --- Diseases --- Metabolic Phenomena --- Proto-Oncogene Proteins --- Health Occupations --- Phenomena and Processes --- Intracellular Signaling Peptides and Proteins --- Natural Science Disciplines --- Cell Physiological Processes --- Oncogene Proteins --- Disciplines and Occupations --- Cell Physiological Phenomena --- Proteins --- Neoplasm Proteins --- Peptides --- Pathology --- Proto-Oncogene Proteins c-bcl-2 --- Metabolism --- Neoplasms --- Physiology --- Amino Acids, Peptides, and Proteins --- Chemicals and Drugs --- Biology --- Health & Biological Sciences --- Cytology --- Medicine. --- Human physiology. --- Molecular biology. --- Proteins. --- Biomedicine. --- Human Physiology. --- Protein Science. --- Biomedicine general. --- Molecular Medicine. --- Proteids --- Biomolecules --- Polypeptides --- Proteomics --- Molecular biochemistry --- Molecular biophysics --- Biochemistry --- Biophysics --- Systems biology --- Human biology --- Medical sciences --- Human body --- Clinical sciences --- Medical profession --- Life sciences --- Physicians --- Tumor markers --- Cell death --- Biochemistry. --- Biological chemistry --- Chemical composition of organisms --- Organisms --- Physiological chemistry --- Chemistry --- Composition --- Health Workforce --- Proteins . --- Biomedicine, general.
Listing 1 - 4 of 4 |
Sort by
|